Cargando…

Validation of 2 Submaximal Cardiorespiratory Fitness Tests in Patients With Breast Cancer Undergoing Chemotherapy

Patients with breast cancer have an impaired cardiorespiratory fitness, in part, due to the toxic effects of anticancer therapy. Physical exercise as a means of rehabilitation for patients with cancer is an emerging area of research and treatment, emphasizing the need for accurate and feasible physi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mijwel, Sara, Cardinale, Daniele, Ekblom-Bak, Elin, Sundberg, Carl Johan, Wengström, Yvonne, Rundqvist, Helene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049956/
https://www.ncbi.nlm.nih.gov/pubmed/27812433
http://dx.doi.org/10.1097/01.REO.0000000000000030
_version_ 1782457813302247424
author Mijwel, Sara
Cardinale, Daniele
Ekblom-Bak, Elin
Sundberg, Carl Johan
Wengström, Yvonne
Rundqvist, Helene
author_facet Mijwel, Sara
Cardinale, Daniele
Ekblom-Bak, Elin
Sundberg, Carl Johan
Wengström, Yvonne
Rundqvist, Helene
author_sort Mijwel, Sara
collection PubMed
description Patients with breast cancer have an impaired cardiorespiratory fitness, in part, due to the toxic effects of anticancer therapy. Physical exercise as a means of rehabilitation for patients with cancer is an emerging area of research and treatment, emphasizing the need for accurate and feasible physical capacity measurements. The purpose of this study was to evaluate the validity of peak oxygen consumption ([Image: see text] o(2peak)) predicted by the Ekblom-Bak test (E-B) and the Åstrand-Rhyming prediction model (A-R). METHODS: Eight patients with breast cancer undergoing chemotherapy participated in the study. Submaximal exercise tests were performed at 2 different submaximal workloads. Estimated [Image: see text] o(2peak) values were obtained by inserting the heart rate (HR) from the 2 workloads into the E-B prediction model and the HR of only the higher workload into the Åstrand nomogram. A 20-W incremental cycle test-to-peak effort was performed to obtain [Image: see text] o(2peak) values. RESULTS: Results from A-R overestimated [Image: see text] o(2peak) by 6% (coefficient of variation = 7%), whereas results from E-B overestimated [Image: see text] o(2peak) with 42% (coefficient of variation = 21%) compared with measured [Image: see text] o(2peak). Pearson's correlation coefficient revealed a significant strong relationship between the estimated [Image: see text] o(2peak) from A-R and the measured [Image: see text] o(2peak) (r = 0.86; P < .05), whereas the relationship between the estimated [Image: see text] o(2peak) from E-B and the measured [Image: see text] o(2peak) resulted in a nonsignificant weak correlation (r = 0.21). CONCLUSION: In a situation where maximal exercise testing is not practical or undesirable from a patient safety perspective, submaximal exercise testing provides an alternative way of estimating [Image: see text] o(2peak). The A-R prediction model appears to be a valid submaximal exercise test for determining cardiorespiratory fitness in this population.
format Online
Article
Text
id pubmed-5049956
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-50499562016-11-01 Validation of 2 Submaximal Cardiorespiratory Fitness Tests in Patients With Breast Cancer Undergoing Chemotherapy Mijwel, Sara Cardinale, Daniele Ekblom-Bak, Elin Sundberg, Carl Johan Wengström, Yvonne Rundqvist, Helene Rehabil Oncol Research Reports Patients with breast cancer have an impaired cardiorespiratory fitness, in part, due to the toxic effects of anticancer therapy. Physical exercise as a means of rehabilitation for patients with cancer is an emerging area of research and treatment, emphasizing the need for accurate and feasible physical capacity measurements. The purpose of this study was to evaluate the validity of peak oxygen consumption ([Image: see text] o(2peak)) predicted by the Ekblom-Bak test (E-B) and the Åstrand-Rhyming prediction model (A-R). METHODS: Eight patients with breast cancer undergoing chemotherapy participated in the study. Submaximal exercise tests were performed at 2 different submaximal workloads. Estimated [Image: see text] o(2peak) values were obtained by inserting the heart rate (HR) from the 2 workloads into the E-B prediction model and the HR of only the higher workload into the Åstrand nomogram. A 20-W incremental cycle test-to-peak effort was performed to obtain [Image: see text] o(2peak) values. RESULTS: Results from A-R overestimated [Image: see text] o(2peak) by 6% (coefficient of variation = 7%), whereas results from E-B overestimated [Image: see text] o(2peak) with 42% (coefficient of variation = 21%) compared with measured [Image: see text] o(2peak). Pearson's correlation coefficient revealed a significant strong relationship between the estimated [Image: see text] o(2peak) from A-R and the measured [Image: see text] o(2peak) (r = 0.86; P < .05), whereas the relationship between the estimated [Image: see text] o(2peak) from E-B and the measured [Image: see text] o(2peak) resulted in a nonsignificant weak correlation (r = 0.21). CONCLUSION: In a situation where maximal exercise testing is not practical or undesirable from a patient safety perspective, submaximal exercise testing provides an alternative way of estimating [Image: see text] o(2peak). The A-R prediction model appears to be a valid submaximal exercise test for determining cardiorespiratory fitness in this population. Lippincott Williams & Wilkins 2016-10 2016-10-14 /pmc/articles/PMC5049956/ /pubmed/27812433 http://dx.doi.org/10.1097/01.REO.0000000000000030 Text en © 2016 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Oncology Section, APTA. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Research Reports
Mijwel, Sara
Cardinale, Daniele
Ekblom-Bak, Elin
Sundberg, Carl Johan
Wengström, Yvonne
Rundqvist, Helene
Validation of 2 Submaximal Cardiorespiratory Fitness Tests in Patients With Breast Cancer Undergoing Chemotherapy
title Validation of 2 Submaximal Cardiorespiratory Fitness Tests in Patients With Breast Cancer Undergoing Chemotherapy
title_full Validation of 2 Submaximal Cardiorespiratory Fitness Tests in Patients With Breast Cancer Undergoing Chemotherapy
title_fullStr Validation of 2 Submaximal Cardiorespiratory Fitness Tests in Patients With Breast Cancer Undergoing Chemotherapy
title_full_unstemmed Validation of 2 Submaximal Cardiorespiratory Fitness Tests in Patients With Breast Cancer Undergoing Chemotherapy
title_short Validation of 2 Submaximal Cardiorespiratory Fitness Tests in Patients With Breast Cancer Undergoing Chemotherapy
title_sort validation of 2 submaximal cardiorespiratory fitness tests in patients with breast cancer undergoing chemotherapy
topic Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049956/
https://www.ncbi.nlm.nih.gov/pubmed/27812433
http://dx.doi.org/10.1097/01.REO.0000000000000030
work_keys_str_mv AT mijwelsara validationof2submaximalcardiorespiratoryfitnesstestsinpatientswithbreastcancerundergoingchemotherapy
AT cardinaledaniele validationof2submaximalcardiorespiratoryfitnesstestsinpatientswithbreastcancerundergoingchemotherapy
AT ekblombakelin validationof2submaximalcardiorespiratoryfitnesstestsinpatientswithbreastcancerundergoingchemotherapy
AT sundbergcarljohan validationof2submaximalcardiorespiratoryfitnesstestsinpatientswithbreastcancerundergoingchemotherapy
AT wengstromyvonne validationof2submaximalcardiorespiratoryfitnesstestsinpatientswithbreastcancerundergoingchemotherapy
AT rundqvisthelene validationof2submaximalcardiorespiratoryfitnesstestsinpatientswithbreastcancerundergoingchemotherapy